10x Genomics, Inc.
TXG
$12.81
$0.504.06%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 447.26M | 426.91M | 393.40M | 398.16M | 380.09M |
Total Receivables | 119.07M | 52.55M | 87.86M | 83.53M | 91.18M |
Inventory | 68.97M | 74.71M | 83.11M | 94.05M | 88.27M |
Prepaid Expenses | 20.37M | 25.57M | 20.02M | 18.16M | 19.61M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 655.66M | 579.73M | 584.39M | 593.89M | 579.16M |
|
|||||
Total Current Assets | 655.66M | 579.73M | 584.39M | 593.89M | 579.16M |
Net Property, Plant & Equipment | 302.41M | 301.66M | 309.94M | 318.34M | 324.16M |
Long-term Investments | 4.51M | 4.51M | 4.51M | 4.51M | 4.51M |
Goodwill | 4.51M | 4.51M | 4.51M | 4.51M | 4.51M |
Total Other Intangibles | 14.71M | 15.19M | 15.67M | 16.15M | 16.66M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 2.67M | 2.30M | 4.13M | 4.90M | 5.19M |
Total Assets | 979.97M | 903.39M | 918.64M | 937.79M | 929.67M |
|
|||||
Total Accounts Payable | 15.94M | 10.07M | 12.91M | 26.21M | 21.25M |
Total Accrued Expenses | 38.92M | 40.91M | 52.07M | 48.87M | 40.52M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 9.67M | 9.44M | 9.29M | 9.42M | 10.82M |
Total Finance Division Other Current Liabilities | 47.70M | 47.48M | 43.37M | 36.74M | 38.43M |
Total Other Current Liabilities | 47.70M | 47.48M | 43.37M | 36.74M | 38.43M |
Total Current Liabilities | 112.22M | 107.90M | 117.63M | 121.24M | 111.02M |
|
|||||
Total Current Liabilities | 112.22M | 107.90M | 117.63M | 121.24M | 111.02M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 77.08M | 70.63M | 73.33M | 76.46M | 78.66M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 17.40M | 17.97M | 17.54M | 17.29M | 15.93M |
Total Liabilities | 206.69M | 196.50M | 208.50M | 214.99M | 205.61M |
|
|||||
Common Stock & APIC | 2.24B | 2.21B | 2.18B | 2.14B | 2.11B |
Retained Earnings | -1.47B | -1.50B | -1.47B | -1.42B | -1.38B |
Treasury Stock & Other | 220.00K | -367.00K | -493.00K | 32.00K | -430.00K |
Total Common Equity | 773.28M | 706.90M | 710.13M | 722.80M | 724.06M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 773.28M | 706.90M | 710.13M | 722.80M | 724.06M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 773.28M | 706.90M | 710.13M | 722.80M | 724.06M |
|